Merck’s Keytruda may be the most talked about drug facing loss of exclusivity but it’s far from the only one, as several of ...

The pharmaceutical industry’s biggest lobbying group is scheduled to meet with President Donald Trump on Thursday, according ...

COUR Pharmaceuticals has been around a while, but not until last year did the company solidify behind its ultimate mission ...

A core group of so-called disease detectives, who track outbreaks, was apparently spared. But other young researchers are out ...

The European Union gave International Flavors & Fragrances the go-ahead to sell its pharma solutions business to French company Roquette for up to $2.85 billion, saying the deal wouldn't stifle ...

Censoring research on how to deliver treatments to those most in need isn’t just nonsensical; it puts lives at risk and ...

Lakeside Holding Limited ('Lakeside' or the 'Company') (Nasdaq: LSH), a U.S.-based cross-border supply chain solution provider with a unique focus on the Asia-Pacific market operating through two ...

Elite Pharmaceuticals, with a market capitalization of $531 million, reported a decline in third-quarter revenue for 2024, falling 8% from the previous year. Despite a strong nine-month performance, ...

The Enhanced Games revealed on Thursday that Don Jr.’s venture firm 1789 Capital will co-lead a multi-million-dollar ...

S&P 500, Dow and Nasdaq end up after Trump holds off on reciprocal tariffs, avoiding a trade war that could slow the economy ...